These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 37313409

  • 1. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q, Zhang P, Zhang X, Feng Y, Li L, Lin H, Yu Y.
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [Abstract] [Full Text] [Related]

  • 2. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
    Yu L, Shen N, Shi Y, Shi X, Fu X, Li S, Zhu B, Yu W, Zhang Y.
    Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
    [Abstract] [Full Text] [Related]

  • 3. A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer.
    Ren Q, Zhang P, Zhang S, Chen W, Chi H, Wang W, Zhang W, Lin H, Yu Y.
    Aging (Albany NY); 2023 Oct 06; 15(19):10501-10523. PubMed ID: 37812215
    [Abstract] [Full Text] [Related]

  • 4. RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signature.
    Si Y, Zhao Z, Meng X, Zhao K.
    Sci Rep; 2024 Oct 06; 14(1):23243. PubMed ID: 39369095
    [Abstract] [Full Text] [Related]

  • 5. Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis.
    Ma J, Chen Z, Hou L.
    Aging (Albany NY); 2024 Sep 26; 16(18):12525-12542. PubMed ID: 39332020
    [Abstract] [Full Text] [Related]

  • 6. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q, Zhang P, Lin H, Feng Y, Chi H, Zhang X, Xia Z, Cai H, Yu Y.
    Front Immunol; 2023 Sep 26; 14():1201573. PubMed ID: 37325647
    [Abstract] [Full Text] [Related]

  • 7. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T, Zhou Z, Xie Z, Fan X, Zhang Y, Zhang Y, Song X, Ruan Y.
    J Cancer Res Clin Oncol; 2023 Oct 26; 149(13):11379-11395. PubMed ID: 37369799
    [Abstract] [Full Text] [Related]

  • 8. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma.
    Liu Y, Jian J, Zhang Y, Wang L, Liu X, Chen Z.
    Front Oncol; 2023 Oct 26; 13():1170893. PubMed ID: 37124542
    [Abstract] [Full Text] [Related]

  • 9. Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
    Shen L, Li A, Cui J, Liu H, Zhang S.
    J Ovarian Res; 2024 Apr 16; 17(1):82. PubMed ID: 38627854
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J.
    Front Immunol; 2021 Apr 16; 12():669750. PubMed ID: 34054840
    [Abstract] [Full Text] [Related]

  • 11. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
    Li C, Song W, Zhang J, Luo Y.
    Front Immunol; 2023 Apr 16; 14():1322147. PubMed ID: 38098487
    [Abstract] [Full Text] [Related]

  • 12. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D, Zhao F, Li J, Qin X, Li S, Niu R.
    Aging (Albany NY); 2023 Aug 09; 15(15):7811-7830. PubMed ID: 37561524
    [Abstract] [Full Text] [Related]

  • 13. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W, Li T, Xie Z, Zhao J, Zhang Y, Ruan Y, Han B.
    J Transl Med; 2024 Jan 14; 22(1):57. PubMed ID: 38221616
    [Abstract] [Full Text] [Related]

  • 14. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z, Wang J, Han W, Zhao L.
    BMC Gastroenterol; 2023 Apr 20; 23(1):132. PubMed ID: 37081402
    [Abstract] [Full Text] [Related]

  • 15. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W, Wang M, Wang M, Liu M.
    Medicine (Baltimore); 2023 Aug 11; 102(32):e34611. PubMed ID: 37565899
    [Abstract] [Full Text] [Related]

  • 16. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
    Shi X, Li Y, Pan S, Liu X, Ke Y, Guo W, Wang Y, Ruan Q, Zhang X, Ma H.
    Sci Rep; 2022 Feb 04; 12(1):1960. PubMed ID: 35121801
    [Abstract] [Full Text] [Related]

  • 17. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M, Zhang H, Ma L, Wang X, Sun D, Feng Z.
    Front Immunol; 2024 Feb 04; 15():1352454. PubMed ID: 38515748
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H, Liu H, Ge Y, Wang X.
    Cancer Cell Int; 2021 Oct 20; 21(1):552. PubMed ID: 34670584
    [Abstract] [Full Text] [Related]

  • 20. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer.
    Wen XY, Wang RY, Yu B, Yang Y, Yang J, Zhang HC.
    Sci Rep; 2023 Sep 20; 13(1):15597. PubMed ID: 37730847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.